CX3CL1-CX3CR1 interaction increases the population of Ly6C-CX3CR1hi macrophages contributing to unilateral ureteral obstruction-induced fibrosis

Journal of Immunology

Volumn 195, Issue 6, 2015, Pages 2797-2805

  Peng, Xiaogang ^a,b,c   Zhang, Jing ^a,b   Xiao, Zhicheng ^a,b   Dong, Yanjun ^a,b   Du, Jie ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; LYMPHOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN 6C; UNCLASSIFIED DRUG; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, MOUSE; CX3CR1 PROTEIN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CELL; CELL COUNT; CELL DIFFERENTIATION; CELL INFILTRATION; CELL SURVIVAL; CELL TRANSPORT; CONTROLLED STUDY; IN VIVO STUDY; KIDNEY CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TARGETING; URETER FIBROSIS; URETER OBSTRUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; FIBROSIS; GENETICS; IMMUNOLOGY; INJURIES; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, LY; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CX3CL1; FIBROSIS; KIDNEY; KIDNEY DISEASES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, CCR2; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; URETERAL OBSTRUCTION;

EID: 84941763575     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403209     Document Type: Article

References (45)

1. Liu, Y. 2011. Cellular and molecular mechanisms of renal fibrosis. Nat. Rev. Nephrol. 7: 684-696.
2. Grande, M. T., and J. M. López-Novoa. 2009. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat. Rev. Nephrol. 5: 319-328.
3. Wang, Y., and D. C. Harris. 2011. Macrophages in renal disease. J. Am. Soc. Nephrol. 22: 21-27.
4. Tapmeier, T. T., A. Fearn, K. Brown, P. Chowdhury, S. H. Sacks, N. S. Sheerin, and W. Wong. 2010. Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int. 78: 351-362.
5. Anders, H. J., V. Vielhauer, M. Frink, Y. Linde, C. D. Cohen, S. M. Blattner, M. Kretzler, F. Strutz, M. Mack, H. J. Gröne, et al. 2002. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J. Clin. Invest. 109: 251-259.
6. Sayyed, S. G., M. Ryu, O. P. Kulkarni, H. Schmid, J. Lichtnekert, S. Grüner, L. Green, P. Mattei, G. Hartmann, and H. J. Anders. 2011. An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int. 80: 68-78.
7. Menke, J., G. C. Zeller, E. Kikawada, T. K. Means, X. R. Huang, H. Y. Lan, B. Lu, J. Farber, A. D. Luster, and V. R. Kelley. 2008. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J. Am. Soc. Nephrol. 19: 1177-1189.
8. Schneider, A., U. Panzer, G. Zahner, U. Wenzel, G. Wolf, F. Thaiss, U. Helmchen, and R. A. Stahl. 1999. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-b. Kidney Int. 56: 135-144.
9. Panzer, U., A. Schneider, J. Wilken, D. A. Thompson, S. B. Kent, and R. A. Stahl. 1999. The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int. 56: 2107-2115.
10. Vielhauer, V., E. Berning, V. Eis, M. Kretzler, S. Segerer, F. Strutz, R. Horuk, H. J. Gröne, D. Schlöndorff, and H. J. Anders. 2004. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int. 66: 2264-2278.
11. Li, L., L. Huang, S. S. Sung, A. L. Vergis, D. L. Rosin, C. E. Rose, Jr., P. I. Lobo, and M. D. Okusa. 2008. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int. 74: 1526-1537.
12. Peng, X., Z. Xiao, J. Zhang, Y. Li, Y. Dong, and J. Du. 2015. IL-17A produced by both gd T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J. Pathol. 235: 79-89.
13. Mionnet, C., V. Buatois, A. Kanda, V. Milcent, S. Fleury, D. Lair, M. Langelot, Y. Lacoeuille, E. Hessel, R. Coffman, et al. 2010. CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat. Med. 16: 1305-1312.
14. Lionakis, M. S., M. Swamydas, B. G. Fischer, T. S. Plantinga, M. D. Johnson, M. Jaeger, N. M. Green, A. Masedunskas, R. Weigert, C. Mikelis, et al. 2013. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J. Clin. Invest. 123: 5035-5051.
15. Koziolek, M. J., H. Schmid, C. D. Cohen, S. Blaschke, B. Hemmerlein, A. Zapf, G. A. Müller, and F. Strutz. 2007. Potential role of fractalkine receptor expression in human renal fibrogenesis. Kidney Int. 72: 599-607.
16. Furuichi, K., J. L. Gao, and P. M. Murphy. 2006. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am. J. Pathol. 169: 372-387.
17. Koziolek, M. J., G. A. Müller, A. Zapf, D. Patschan, H. Schmid, C. D. Cohen, S. Koschnick, R. Vasko, C. Bramlage, and F. Strutz. 2010. Role of CX3Cchemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure. Nephrol. Dial. Transplant. 25: 684-698.
18. Koziolek, M. J., R. Vasko, C. Bramlage, G. A. Müller, and F. Strutz. 2009. The CX(3)C-chemokine fractalkine in kidney diseases. Mini Rev. Med. Chem. 9: 1215-1228.
19. Lionakis, M. S., J. K. Lim, C. C. Lee, and P. M. Murphy. 2011. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J. Innate Immun. 3: 180-199.
20. Yang, M., J. Zheng, Y. Miao, Y. Wang, W. Cui, J. Guo, S. Qiu, Y. Han, L. Jia, H. Li, et al. 2012. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler. Thromb. Vasc. Biol. 32: 1675-1686.
21. Tsuda, M., W. Zhang, G. X. Yang, K. Tsuneyama, Y. Ando, K. Kawata, O. Park, P. S. Leung, R. L. Coppel, A. A. Ansari, et al. 2013. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFb receptor type II mice. Hepatology 57: 806-816.
22. Rivollier, A., J. He, A. Kole, V. Valatas, and B. L. Kelsall. 2012. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209: 139-155.
23. Cheng, J., L. D. Truong, X. Wu, D. Kuhl, F. Lang, and J. Du. 2010. Serum- and glucocorticoid-regulated kinase 1 is upregulated following unilateral ureteral obstruction causing epithelial-mesenchymal transition. Kidney Int. 78: 668-678.
24. Li, Y., C. Zhang, Y. Wu, Y. Han, W. Cui, L. Jia, L. Cai, J. Cheng, H. Li, and J. Du. 2012. Interleukin-12p35 deletion promotes CD4 T-cell-dependent macrophage differentiation and enhances angiotensin II-Induced cardiac fibrosis. Arterioscler. Thromb. Vasc. Biol. 32: 1662-1674.
25. Tsou, C. L., W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian, S. P. Weisberg, M. Mack, and I. F. Charo. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117: 902-909.
26. Sato, M., Y. Muragaki, S. Saika, A. B. Roberts, and A. Ooshima. 2003. Targeted disruption of TGF-b1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 112: 1486-1494.
27. Miyajima, A., J. Chen, C. Lawrence, S. Ledbetter, R. A. Soslow, J. Stern, S. Jha, J. Pigato, M. L. Lemer, D. P. Poppas, et al. 2000. Antibody to transforming growth factor-b ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 58: 2301-2313.
28. Bachmann, M. F., M. Kopf, and B. J. Marsland. 2006. Chemokines: more than just road signs. Nat. Rev. Immunol. 6: 159-164.
29. Landsman, L., L. Bar-On, A. Zernecke, K. W. Kim, R. Krauthgamer, E. Shagdarsuren, S. A. Lira, I. L. Weissman, C. Weber, and S. Jung. 2009. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113: 963-972.
30. Barlic, J., Y. Zhang, J. F. Foley, and P. M. Murphy. 2006. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferatoractivated receptor gamma-dependent pathway. Circulation 114: 807-819.
31. Nascimento, M., S. C. Huang, A. Smith, B. Everts, W. Lam, E. Bassity, E. L. Gautier, G. J. Randolph, and E. J. Pearce. 2014. Ly6Chi monocyte recruitment is responsible for Th2 associated host-protective macrophage accumulation in liver inflammation due to schistosomiasis. PLoS Pathog. 10: e1004282.
32. Kitagawa, K., T. Wada, K. Furuichi, H. Hashimoto, Y. Ishiwata, M. Asano, M. Takeya, W. A. Kuziel, K. Matsushima, N. Mukaida, and H. Yokoyama. 2004. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am. J. Pathol. 165: 237-246.
33. Tacke, F., D. Alvarez, T. J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, et al. 2007. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117: 185-194.
34. Arnold, L., A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069.
35. Nahrendorf, M., F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J. L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204: 3037-3047.
36. Lin, S. L., A. P. Castano, B. T. Nowlin, M. L. Lupher, Jr., and J. S. Duffield. 2009. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J. Immunol. 183: 6733-6743.
37. Liu, Y., K. N. Stewart, E. Bishop, C. J. Marek, D. C. Kluth, A. J. Rees, and H. M. Wilson. 2008. Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo. J. Immunol. 180: 6270-6278.
38. Lumeng, C. N., J. L. Bodzin, and A. R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117: 175-184.
39. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, and O. Yoshie. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530.
40. Meucci, O., A. Fatatis, A. A. Simen, T. J. Bushell, P. W. Gray, and R. J. Miller. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95: 14500-14505.
41. Karlmark, K. R., H. W. Zimmermann, C. Roderburg, N. Gassler, H. E. Wasmuth, T. Luedde, C. Trautwein, and F. Tacke. 2010. The fractalkine receptor CX-CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology 52: 1769-1782.
42. Engel, D. R., T. A. Krause, S. L. Snelgrove, S. Thiebes,M. J. Hickey, P. Boor, A. R. Kitching, and C. Kurts. 2015. CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages. J. Immunol. 194: 1628-1638.
43. Bourd-Boittin, K., L. Basset, D. Bonnier, A. L'helgoualc'h, M. Samson, and N. Théret. 2009. CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver. J. Cell. Mol. Med. 13(8A): 1526-1535.
44. Fong, A. M., L. A. Robinson, D. A. Steeber, T. F. Tedder, O. Yoshie, T. Imai, and D. D. Patel. 1998. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188: 1413-1419.
45. Gröne, H. J., C. D. Cohen, E. Gröne, C. Schmidt, M. Kretzler, D. Schlöndorff, and P. J. Nelson. 2002. Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney. J. Am. Soc. Nephrol. 13: 957-967.